The ELRIG Protein Sciences in Drug Discovery 2026 conference is a premier gathering designed to bridge the gap between academic research and industrial application in the field of protein engineering and analysis. As drug discovery becomes increasingly complex, the role of protein sciences has expanded from simple reagent production to being a cornerstone of therapeutic design, particularly in the realms of biologics, PROTACs, and molecular glues.
This two-day event provides a comprehensive deep dive into the latest technological advancements and methodological breakthroughs. Attendees will explore high-throughput protein expression, advanced purification techniques, and cutting-edge biophysical characterization. The program is curated to address the current bottlenecks in the industry, such as protein stability, "undruggable" targets, and the integration of artificial intelligence in protein design.
Beyond the podium presentations, the event features a vibrant exhibition hall where leading vendors showcase the latest automation and robotics technologies that are transforming laboratory workflows. Networking is a core component of the ELRIG experience; the conference offers dedicated sessions for scientists to connect with peers, potential collaborators, and industry mentors. The "Breakthrough Zone" provides a platform for early-career researchers and startups to present their innovative work to a global audience. Whether you are looking to refine your technical skills or understand the strategic direction of the biopharma industry, this conference serves as a vital touchpoint for the protein science community in the UK and Europe.
Hinxton Hall Conference Centre,
Cambridge
